Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,452 | 81 | 95.9% |
| Education | $61.95 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $274.41 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $203.26 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $199.56 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $183.00 | 9 | $0 (2024) |
| Novo Nordisk Inc | $111.87 | 7 | $0 (2024) |
| Lilly USA, LLC | $86.68 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.78 | 5 | $0 (2024) |
| PFIZER INC. | $68.00 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $51.38 | 3 | $0 (2023) |
| Amgen Inc. | $50.04 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $676.40 | 38 | AstraZeneca Pharmaceuticals LP ($183.00) |
| 2023 | $653.51 | 35 | Astellas Pharma US Inc ($121.90) |
| 2022 | $184.45 | 9 | ABBVIE INC. ($105.74) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Biological | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Biological | ||||||
| 09/05/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Biological | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 07/23/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Hematology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes Care | ||||||
| 05/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VACCINES | ||||||
| 04/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Cardiovascular | ||||||
| 04/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Biological | ||||||
| 04/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,020 | 1,433 | $163,221 | $55,959 |
| 2022 | 10 | 338 | 416 | $45,192 | $16,785 |
| 2021 | 15 | 599 | 912 | $67,865 | $25,951 |
| 2020 | 8 | 166 | 208 | $17,001 | $8,562 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 322 | $61,180 | $24,060 | 39.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 85 | 105 | $30,450 | $9,857 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 140 | $18,900 | $6,165 | 32.6% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 85 | 105 | $10,710 | $5,279 | 49.3% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 80 | 98 | $12,348 | $3,370 | 27.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,300 | $1,406 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $3,128 | $1,223 | 39.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 137 | $3,288 | $1,151 | 35.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 85 | 105 | $5,985 | $799.05 | 13.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 72 | 97 | $5,917 | $635.74 | 10.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 64 | 152 | $2,888 | $609.80 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $931.00 | $532.95 | 57.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 36 | $2,232 | $342.72 | 15.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 22 | 27 | $972.00 | $333.45 | 34.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 52 | 62 | $992.00 | $192.82 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 116 | $14,176 | $6,031 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 37 | $6,962 | $3,233 | 46.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 30 | 32 | $9,280 | $3,004 | 32.4% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 54 | 59 | $7,310 | $2,935 | 40.1% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2022 | 13 | 13 | $1,638 | $447.07 | 27.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 26 | $1,166 | $359.48 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 41 | $2,345 | $314.46 | 13.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 26 | 56 | $1,064 | $295.84 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 13 | 13 | $741.00 | $98.93 | 13.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 23 | $510.00 | $65.60 | 12.9% |
About Lori Beisel
Lori Beisel is a Registered Nurse healthcare provider based in Columbia, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235683665.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lori Beisel has received a total of $1,514 in payments from pharmaceutical and medical device companies, with $676.40 received in 2024. These payments were reported across 82 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,452).
As a Medicare-enrolled provider, Beisel has provided services to 2,123 Medicare beneficiaries, totaling 2,969 services with total Medicare billing of $107,256. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Columbia, MS
- Active Since 08/15/2016
- Last Updated 09/01/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1235683665
Products in Payments
- XARELTO (Drug) $203.26
- Veozah (Drug) $108.20
- AIRSUPRA (Drug) $101.59
- VRAYLAR (Drug) $91.80
- FARXIGA (Drug) $81.41
- MOUNJARO (Drug) $69.94
- PREVNAR 20 (Biological) $68.00
- QULIPTA (Drug) $60.24
- UBRELVY (Drug) $57.20
- AREXVY (Drug) $51.38
- Ozempic (Drug) $51.01
- EVENITY (Biological) $50.04
- JARDIANCE (Drug) $48.58
- Linzess (Drug) $44.15
- LINZESS (Drug) $37.12
- Wegovy (Drug) $35.46
- Myrbetriq (Drug) $29.41
- BELSOMRA (Drug) $21.92
- FREESTYLE LIBRE 3 (Device) $18.65
- LEQVIO (Drug) $18.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Columbia
Amanda Goke, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $17,238
Stephanie Whitbey, N.p, N.P
Registered Nurse — Payments: $9,510
Mrs. Andrea Oates, Msn, Fnp, MSN, FNP
Registered Nurse — Payments: $7,087
Jamie Markway, Fnp, FNP
Registered Nurse — Payments: $6,251
Tomeeka Hawthorne, Rn, RN
Registered Nurse — Payments: $6,028
Mrs. Cynthia Rose, Rn, RN
Registered Nurse — Payments: $4,516